Dastolfo-Hromack Christina, Thomas Tracey L, Rosen Clark A, Gartner-Schmidt Jackie
University of Pittsburgh Voice Center, Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, U.S.A.
Laryngoscope. 2016 Nov;126(11):2546-2551. doi: 10.1002/lary.25962. Epub 2016 Jun 27.
OBJECTIVES/HYPOTHESIS: The objectives of this study were to describe singing voice therapy (SVT), describe referred patient characteristics, and document the outcomes of SVT.
Retrospective.
Records of patients receiving SVT between June 2008 and June 2013 were reviewed (n = 51). All diagnoses were included. Demographic information, number of SVT sessions, and symptom severity were retrieved from the medical record. Symptom severity was measured via the 10-item Singing Voice Handicap Index (SVHI-10). Treatment outcome was analyzed by diagnosis, history of previous training, and SVHI-10.
SVHI-10 scores decreased following SVT (mean change = 11, 40% decrease) (P < .001). Approximately 18% (n = 9) of patient SVHI-10 scores decreased to normal range. The average number of sessions attended was three (± 2); patients who concurrently attended singing lessons (n = 10) also completed an average of three SVT sessions. Primary muscle tension dysphonia (MTD1) and benign vocal fold lesion (lesion) were the most common diagnoses. Most patients (60%) had previous vocal training. SVHI-10 decrease was not significantly different between MTD and lesion.
This is the first outcome-based study of SVT in a disordered population. Diagnosis of MTD or lesion did not influence treatment outcomes. Duration of SVT was short (approximately three sessions). Voice care providers are encouraged to partner with a singing voice therapist to provide optimal care for the singing voice. This study supports the use of SVT as a tool for the treatment of singing voice disorders.
4 Laryngoscope, 126:2546-2551, 2016.
目的/假设:本研究的目的是描述歌唱嗓音治疗(SVT),描述转诊患者的特征,并记录SVT的治疗结果。
回顾性研究。
回顾了2008年6月至2013年6月期间接受SVT治疗的患者记录(n = 51)。纳入所有诊断。从病历中获取人口统计学信息、SVT疗程数和症状严重程度。症状严重程度通过10项歌唱嗓音障碍指数(SVHI-10)进行测量。通过诊断、既往训练史和SVHI-10分析治疗结果。
SVT后SVHI-10评分降低(平均变化 = 11,降低40%)(P <.001)。约18%(n = 9)的患者SVHI-10评分降至正常范围。平均就诊疗程数为3次(± 2);同时参加歌唱课程的患者(n = 10)平均也完成了3次SVT疗程。原发性肌肉紧张性发声障碍(MTD1)和声带良性病变(病变)是最常见的诊断。大多数患者(60%)既往有嗓音训练。MTD和病变之间SVHI-10降低无显著差异。
这是第一项在患有嗓音疾病人群中基于结果的SVT研究。MTD或病变的诊断不影响治疗结果。SVT疗程较短(约3次)。鼓励嗓音护理提供者与歌唱嗓音治疗师合作,为歌唱嗓音提供最佳护理。本研究支持将SVT用作治疗歌唱嗓音障碍的工具。
4 《喉镜》,126:2546 - 2551,2016年。